5 amino 1mq research compound 5-Amino-1MQ 50mg 5 Amino 1MQ | Research
Description
Safety and Pharmacology Evaluations : Conducting preclinical toxicology, pharmacokinetic, and receptor-binding studies to characterize how AOD 9604 is handled in vivo and confirm it does not activate growth hormone-like proliferative pathways
No adverse effects have been reported with ingestion of normal daily requirements during pregnancy
Given its wide-ranging responsibilities, maintaining adequate B12 levels is paramount for overall health and vitality
Specific Adverse Effects Reported in Clinical Trials While the overall safety profile was excellent, clinical trials documented all adverse events regardless of severity or causality
